AIMS/HYPOTHESIS: Glucose-induced insulin secretion is attributed to a rise of beta cell cytosolic free [Ca(2+)] ([Ca(2+)](c)) (triggering pathway) and amplification of the action of Ca(2+). This concept of amplification rests on observations that glucose can increase Ca(2+)-induced insulin secretion without further elevating an imposed already high [Ca(2+)](c). However, it remains possible that this amplification results from an increase in [Ca(2+)] just under the plasma membrane ([Ca(2+)](SM)), which escaped detection by previous measurements of global [Ca(2+)](c). This was the hypothesis that we tested here by measuring [Ca(2+)](SM). METHODS: The genetically encoded Ca(2+) indicators D3-cpv (untargeted) and LynD3-cpv (targeted to plasma membrane) were expressed in clusters of mouse beta cells. LynD3-cpv was also expressed in beta cells within intact islets. [Ca(2+)](SM) changes were monitored using total internal reflection fluorescence microscopy. Insulin secretion was measured in parallel. RESULTS: Beta cells expressing D3cpv or LynD3cpv displayed normal [Ca(2+)] changes and insulin secretion in response to glucose. Distinct [Ca(2+)](SM) fluctuations were detected during repetitive variations of KCl between 30 and 32-35 mmol/l, attesting to the adequate sensitivity of our system. When the amplifying pathway was evaluated (high KCl + diazoxide), increasing glucose from 3 to 15 mmol/l consistently lowered [Ca(2+)](SM) while stimulating insulin secretion approximately two fold. Blocking Ca(2+) uptake by the endoplasmic reticulum largely attenuated the [Ca(2+)](SM) decrease produced by high glucose but did not unmask localised [Ca(2+)](SM) increases. CONCLUSIONS/ INTERPRETATION: Glucose can increase Ca(2+)-induced insulin secretion without causing further elevation of beta cell [Ca(2+)](SM). The phenomenon is therefore a true amplification of the triggering action of Ca(2+).
AIMS/HYPOTHESIS: Glucose-induced insulin secretion is attributed to a rise of beta cell cytosolic free [Ca(2+)] ([Ca(2+)](c)) (triggering pathway) and amplification of the action of Ca(2+). This concept of amplification rests on observations that glucose can increase Ca(2+)-induced insulin secretion without further elevating an imposed already high [Ca(2+)](c). However, it remains possible that this amplification results from an increase in [Ca(2+)] just under the plasma membrane ([Ca(2+)](SM)), which escaped detection by previous measurements of global [Ca(2+)](c). This was the hypothesis that we tested here by measuring [Ca(2+)](SM). METHODS: The genetically encoded Ca(2+) indicators D3-cpv (untargeted) and LynD3-cpv (targeted to plasma membrane) were expressed in clusters of mouse beta cells. LynD3-cpv was also expressed in beta cells within intact islets. [Ca(2+)](SM) changes were monitored using total internal reflection fluorescence microscopy. Insulin secretion was measured in parallel. RESULTS: Beta cells expressing D3cpv or LynD3cpv displayed normal [Ca(2+)] changes and insulin secretion in response to glucose. Distinct [Ca(2+)](SM) fluctuations were detected during repetitive variations of KCl between 30 and 32-35 mmol/l, attesting to the adequate sensitivity of our system. When the amplifying pathway was evaluated (high KCl + diazoxide), increasing glucose from 3 to 15 mmol/l consistently lowered [Ca(2+)](SM) while stimulating insulin secretion approximately two fold. Blocking Ca(2+) uptake by the endoplasmic reticulum largely attenuated the [Ca(2+)](SM) decrease produced by high glucose but did not unmask localised [Ca(2+)](SM) increases. CONCLUSIONS/ INTERPRETATION:Glucose can increase Ca(2+)-induced insulin secretion without causing further elevation of beta cell [Ca(2+)](SM). The phenomenon is therefore a true amplification of the triggering action of Ca(2+).
Authors: S Barg; X Ma; L Eliasson; J Galvanovskis; S O Göpel; S Obermüller; J Platzer; E Renström; M Trus; D Atlas; J Striessnig; P Rorsman Journal: Biophys J Date: 2001-12 Impact factor: 4.033
Authors: Paolo Pinton; Takashi Tsuboi; Edward K Ainscow; Tullio Pozzan; Rosario Rizzuto; Guy A Rutter Journal: J Biol Chem Date: 2002-07-30 Impact factor: 5.157
Authors: Helena Maria Ximenes; Adama Kamagate; Françoise Van Eylen; Angelo Carpinelli; André Herchuelz Journal: J Biol Chem Date: 2003-04-07 Impact factor: 5.157
Authors: Francesca Semplici; Martine Vaxillaire; Sarah Fogarty; Meriem Semache; Amélie Bonnefond; Ghislaine Fontés; Julien Philippe; Gargi Meur; Frederique Diraison; Richard B Sessions; Jared Rutter; Vincent Poitout; Philippe Froguel; Guy A Rutter Journal: J Biol Chem Date: 2011-11-07 Impact factor: 5.157
Authors: David J Hodson; Andrei I Tarasov; Silvia Gimeno Brias; Ryan K Mitchell; Natalie R Johnston; Shahab Haghollahi; Matthew C Cane; Marco Bugliani; Piero Marchetti; Domenico Bosco; Paul R Johnson; Stephen J Hughes; Guy A Rutter Journal: Mol Endocrinol Date: 2014-04-25
Authors: Muhammad Rizwan Alam; Lukas N Groschner; Warisara Parichatikanond; Liang Kuo; Alexander I Bondarenko; Rene Rost; Markus Waldeck-Weiermair; Roland Malli; Wolfgang F Graier Journal: J Biol Chem Date: 2012-08-17 Impact factor: 5.157